Nasdaq:US$14.22 (+0.06) | HKEX:HK$22.00 (-0.24) | AIM:£2.18 (+0.04)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 其他业务 | 2014-04-17

Chi-Med and Sinopharm complete regulatory approval for the establishment of new China drug distribution and marketing Joint Venture